Home - International News - Novo Nordisk’s next obesity drug falls short of Lilly rival, wiping billions off its market value By Syndication Editor Feb 23, 2026 Novo Nordisk’s next obesity drug falls short of Lilly rival, wiping billions off its market value International News 10 Total views No comments Syndication Editor Related Posts Global fashion retailer closing all stores after 33 years Jim Cramer: This Stock’s ‘Hot As A Pistol,’ Sell Super Micro Computer Comments (No) Leave a Reply Cancel Reply Save my name, email, and website in this browser for the next time I comment. Hide Comments
Comments (No)